Status:
RECRUITING
oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
Lead Sponsor:
Hôpital NOVO
Conditions:
Giant Cell Arteritis (GCA)
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether the measure of the optic nerve sheath is a reliable diagnostic marker for giant cell arteritis
Detailed Description
Giant Cell Arteritis (GCA) is a vasculitis affecting large and medium-sized vessels. It predominantly occurs in women, with a sex ratio of 3:1, and mainly affects individuals around 70 years of age. G...
Eligibility Criteria
Inclusion
- Patient with suspected GCA
- Patient over 50 years
Exclusion
- Patient with history of GCA
- Patient with a history of polymyalgia rheumatic (PMR) without initial PET scan
- Patient with a history of retinal disease, demyelinating disease, or intracranial hypertension
- Use of corticosteroids \> 0.5mg/kg in the last 2 weeks
Key Trial Info
Start Date :
September 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT07001059
Start Date
September 4 2025
End Date
March 31 2028
Last Update
September 12 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhumatology departement - Centre Hospitalier Aix en Provence
Aix-en-Provence, France
2
Rhumatology department - Centre Hospitalier Universitaire de Brest
Brest, France
3
Internal Medecine Department- CHU Caen
Caen, France
4
Internal Medicine and Clinical Immulogy department - Centre Hospitalier Universitaire de Dijon
Dijon, France